Fosun Reports 160% Net Profit Surge in 1H2026 on Core Business Focus…

Event summary

Fosun's 1H2026 revenue held steady at RMB86.96 billion despite divestments, with net profit surging 160.3% YoY to RMB1.72 billion.
Core businesses (pharma, insurance, tourism) generated 73.5% of total revenue, with industrial profit up 17% YoY.
Overseas revenue grew 5.3% YoY to RMB49.16 billion, now comprising 56.5% of total revenue.
Fosun raised RMB12 billion from non-core asset sales, boosting cash reserves to RMB61.214 billion.
MSCI upgraded Fosun's ESG rating to AAA, with inclusion in S&P Global's Sustainability Yearbook 2026.

The big picture

Fosun's strong 1H2026 results validate its multi-year pivot toward core businesses and globalization. The conglomerate's ability to grow profits while divesting non-strategic assets highlights operational discipline. With overseas revenue now over half of total sales, Fosun is executing a rare China-to-global integration strategy. The ESG upgrades suggest this shift is resonating with international investors.

What we're watching

Profitability Momentum: Whether Fosun can sustain its 160% net profit growth through the second half of 2026.
Global Expansion: The pace at which Fosun's overseas revenue share grows beyond 56.5%.
Innovation Payoff: How Fosun's RMB4.2 billion AI and tech investments translate into tangible business value.